Literature DB >> 12709353

High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea.

Dongeun Yong1, Jong Hee Shin, Sinyoung Kim, Youngsik Lim, Jong Hwa Yum, Kyungwon Lee, Yunsop Chong, Adolf Bauernfeind.   

Abstract

PER-1, an extended-spectrum beta-lactamase, has been reported only in Europe. We detected PER-1 in 53 of 97 acinetobacters in Korea, mainly in the sputum of intensive care unit patients. Pulsed-field gel electrophoresis analysis suggested that clonal spread had occurred. Only PCR reliably detected PER-1 producers. PER-1 producers may also exist in other Asian countries.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12709353      PMCID： PMC153336          DOI： 10.1128/AAC.47.5.1749-1751.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France.

Authors:  L Poirel; A Karim; A Mercat; I Le Thomas; H Vahaboglu; C Richard; P Nordmann
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

2.  Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains.

Authors:  Haluk Vahaboglu; Figen Coskunkan; Ozlem Tansel; Recep Ozturk; Nursu Sahin; Iftahar Koksal; Bekir Kocazeybek; Muserref Tatman-Otkun; Hakan Leblebicioglu; Mehmet Ali Ozinel; Halis Akalin; Sesin Kocagoz; Volkan Korten
Journal:  J Med Microbiol       Date:  2001-07       Impact factor: 2.472

3.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.

Authors:  H Vahaboglu; R Oztürk; G Aygün; F Coşkunkan; A Yaman; A Kaygusuz; H Leblebicioglu; I Balik; K Aydin; M Otkun
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

5.  bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.

Authors:  Kyungwon Lee; Jong Back Lim; Jong Hwa Yum; Dongeun Yong; Yunsop Chong; June Myung Kim; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

6.  Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.

Authors:  A Bauernfeind; I Stemplinger; R Jungwirth; P Mangold; S Amann; E Akalin; O Anğ; C Bal; J M Casellas
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

7.  In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli.

Authors:  Y Chong; K Lee; O H Kwon
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

8.  Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases.

Authors:  P Nordmann; T Naas
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

9.  Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Authors:  P Nordmann; E Ronco; T Naas; C Duport; Y Michel-Briand; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey.

Authors:  H Vahaboglu; L M Hall; L Mulazimoglu; S Dodanli; I Yildirim; D M Livermore
Journal:  J Med Microbiol       Date:  1995-10       Impact factor: 2.472
  10 in total
  33 in total

1.  Biochemical characterization of PER-2 and genetic environment of blaPER-2.

Authors:  Pablo Power; José Di Conza; María Margarita Rodríguez; Bárbara Ghiglione; Juan A Ayala; José María Casellas; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

Review 2.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

3.  Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India.

Authors:  Pooja Singla; Rama Sikka; Antariksh Deeep; Deep Gagneja; Uma Chaudhary
Journal:  J Clin Diagn Res       Date:  2014-04-15

4.  Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene.

Authors:  Thierry Naas; Daniel Aubert; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  Molecular Epidemiology and Genetic Characteristics of Various blaPER Genes in Shanghai, China.

Authors:  Lianyan Xie; Jun Wu; Fangfang Zhang; Lizhong Han; Xiaokui Guo; Yuxing Ni; Jingyong Sun
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  Tn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants.

Authors:  Elisabetta Mantengoli; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates.

Authors:  Yu Mi Lim; Kyeong Seob Shin; Jungmin Kim
Journal:  J Clin Microbiol       Date:  2006-12-27       Impact factor: 5.948

8.  Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes.

Authors:  Ahmed Hamouda; Benjamin A Evans; Kevin J Towner; Sebastian G B Amyes
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

9.  Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.

Authors:  Ramamourthy Gopal; Young Gwon Kim; Jun Ho Lee; Seog Ki Lee; Jeong Don Chae; Byoung Kwan Son; Chang Ho Seo; Yoonkyung Park
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 10.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.